Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-23-013213
Filing Date
2023-04-26
Accepted
2023-04-26 16:01:31
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 innatepharma424b5april2023.htm 424B5 896656
2 image_01a.jpg GRAPHIC 15911
3 image_0a.jpg GRAPHIC 36302
4 innatepharmalogoa.jpg GRAPHIC 52807
5 pipea.jpg GRAPHIC 166640
6 prospectussummary1aa.jpg GRAPHIC 307265
  Complete submission text file 0001628280-23-013213.txt   1692015
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252074 | Film No.: 23849614
SIC: 2836 Biological Products, (No Diagnostic Substances)